Clinical Trial Detail

NCT ID NCT03797391
Title A Dose Escalation Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Shanghai EpimAb Biotherapeutics Co., Ltd.
Indications

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

EMB-01

Age Groups: adult senior

No variant requirements are available.